Filing Flows › Harmony Biosciences Holdings (HRMY) › How it makes money
How Harmony Biosciences Holdings (HRMY) makes money
Harmony Biosciences Holdings (HRMY) made $269M of revenue in the third quarter 2026 (Q3 2026), +12% from a year earlier. Of every dollar of revenue, 70¢ was left as gross profit, 20¢ was left as operating profit, 18¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $269M | 100.0% |
| Cost of revenue | $80.7M | 30.0% |
| Gross profit | $188M | 70.0% |
| Operating expenses | $134M | 49.8% |
| Operating profit | $54.2M | 20.2% |
| Income tax | $11.1M | 4.1% |
| Net earnings | $48.2M | 17.9% |
| Operating cash flow | $76.7M | 28.5% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $269M | +12% |
| Q2 2026 | $261M | +30% |
| Q1 2026 | $215M | +17% |
| Q4 2025 | $244M | +21% |
| Q3 2025 | $239M | +29% |
| Q2 2025 | $200M | +16% |
| Q1 2025 | $185M | +20% |
From Harmony Biosciences Holdings' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Harmony Biosciences Holdings make money?
Harmony Biosciences Holdings (HRMY) made $269M of revenue in the third quarter 2026 (Q3 2026), +12% from a year earlier. Of every dollar of revenue, 70¢ was left as gross profit, 20¢ was left as operating profit, 18¢ was left as net earnings.
What is Harmony Biosciences Holdings' profit margin?
Net earnings were $48.2M, 17.9% of revenue, in the third quarter 2026; the operating margin was 20.2%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.